BCW Index Gains 2 Percent Amid Rise in Tech Stocks | GenomeWeb
The BCW Index gained 2 percent for the week ended Tuesday, as 15 of the 16 companies in the Index either gained ground or were flat for the period. The upswing was consistent with gains realized by tech stocks during the week.
Bruker Biosciences led gainers with a 5-percent increase, followed by PerkinElmer, which rose 4.4 percent. The only firm in the Index to lose ground for the trading period was Stratagene, whose shares dropped 8.5 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.